This announcement is a separate document:
中國抗體-B：於二零二一年十二月十四日舉行之股東特別大會之投票表決結果；及非執行董事變動
SINOMAB BIO-B: POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETINGHELD ON 14 DECEMBER 2021; ANDCHANGE OF NON-EXECUTIVE DIRECTORS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.